Monthly Archives: October 2015

Following release of WHO TB report, a discussion examines how to end an epidemic

By on .

“For some reason, diseases usually start equally among everyone in society, but every disease always falls down to the poorest of the poor,” Larry Gostin said Wednesday. “Now we see that tuberculosis has fallen down to the poorest of the poor,” Gostin, O’Neill Institute Chair of Georgetown University and director of the World Health Organization […]

WHO report shows TB, treatable and curable, surpassing HIV as No. 1 infectious disease killer

By on .

While tuberculosis deaths have dropped by nearly half since 1990, an estimated 4400 people die daily from TB, a disease “that often strikes the voiceless . . .” As World Health Organization report is released, USAID official says White House “is close to” releasing plan for multidrug-resistant tuberculosis . . . With the deaths of […]

Lancet TB series on local data, active case-finding, preventive treatment, community input and more . . . We’re reading how to end tuberculosis

By on .

A Lancet special series developed by an international team and led by Dr. Salmaan Keshavjee of Harvard Medical School’s Department of Global Health and Social Medicine lays out proven elements of tuberculosis control and how they can be worked into comprehensive approaches in high-risk, low-resource settings. And, at the same time the latest antiretroviral treatment […]

Is plan for drug-resistant TB delayed amid cost concerns, while cost of delay goes unnoticed?

By on .

Recent history of White House proposed cuts to tuberculosis programming and research raise questions on status of Administration plan for MDR-TB  A Huffington Post article last week described the individual impact, the economic damage and the global threat of drug-resistant tuberculosis in stark and efficient terms, starting with the case of one woman in the U.S., a teacher […]

Accessible global health innovations critical to achieving Sustainable Development Goals

By on .

“You can design the most beautiful vaccine or other technology but without proper marketing or dissemination, it will sit on a shelf,” Kaitlin Christenson of PATH said Wednesday. Emphasizing that access and affordability are key to the success of innovations addressing global health concerns, she was speaking at  a Congressional panel focused on the role […]

Risks and challenges of people who inject drugs, earn income through sex work recognized, but seldom addressed in adequate, joined responses

By on .

Recognized as “key” and “most at risk,” populations to reach in responses to HIV globally, people who inject drugs and people who earn income through sex work face double the risks and double the barriers to support, protection and health services when their categories overlap. Their risks and challenges triple if they also are sexual […]

“A sweetheart deal” “deplorable” “immoral and unacceptable” “Massive victory for big pharma” . . . We’re reading about TPP’s pharma rules, and an update on a 5000-percent price hike

By on .

(Spoiler alert: The price of a life-saving treatment for toxoplasmosis remains unchanged, a month after company CEO Martin Shkreli said it would drop . . . )  But first: The world got glimpse of what the Trans Pacific Partnership offers pharmaceutical companies last week with the WikiLeaks release of the treaty’s Intellectual Property Rights chapter, a […]

TB diagnostic tool development and access remain first obstacles to finding and treating tuberculosis where it poses greatest threats

By on .

In the obstacle course that detecting, treating and curing tuberculosis can present to populations most affected by the disease, the first hurdle, caused by gaps in technology appropriate to realities where the disease flourishes, remains diagnosis. In turn, obstacles to developing diagnostic tools and getting them on the ground, include lack of resources to test […]

Malaria in the time of Ebola: Alleviating health system impacts during crises

By on .

The following is a guest post by True Claycombe, Policy Manager, Friends of the Global Fight Against AIDS, Tuberculosis and Malaria Friends of the Global Fight against AIDS, Tuberculosis and Malaria welcomed malaria expert Dr. Susie Nasr for a recent webinar to discuss malaria and the Global Fund’s role during the Ebola outbreak in West […]

Findings of Ebola in semen nine months after illness add to unknowns about outbreak control

By on .

Findings published this week tell of the persistence and consequence of Ebola virus in recovered patients, raising questions of new challenges to ending the largest recorded outbreak of the disease. At the same time, the critical condition of a nurse discharged from treatment for the virus last January reinforces concerns about the threat and scope […]